The role of IgE in asthma.

Important note: Information in this article was accurate in 1999. The state of the art may have changed since the publication date.

The role of IgE in asthma.

Clin Exp Allergy. 1998 Nov;28 Suppl 5:104-9; discussion 117-8. Unique Identifier : AIDSLINE MED/99140984
Yssel H; Abbal C; Pene J; Bousquet J; Clinique des Maladies Respiratoires and INSERM U454, Hopital; Arnaud de Villeneuve, Montpellier, France.

Abstract: Asthma is a multifactorial and complex disease in which allergic factors and non-allergic triggers interact and result in bronchial obstruction and inflammation. Allergenic sensitization is important in the development of asthma and, although links between inhalant allergy and asthma have been known for many years, they have recently been re-emphasized. Indoor allergens are associated with asthma prevalence, severity and exacerbations whereas outdoor allergens such as pollens are associated with exacerbations. Moreover, there is a link between total IgE and asthma which appears to be independent of allergen sensitization. One of the typical aspects of airway inflammation of asthma is the infiltration of the airway wall by T helper type 2 (Th2) cells. These cells are attracted to inflammatory sites by adhesion molecules and chemokines among which CCR3 and CXCR4 receptors appear to be of importance. Differentiation of B cells into IgE-secreting plasma cells is a complex cascade of events in which cytokines play a crucial role. Both IL-4 and IL-13 are inducing IgE synthesis whereas IFN-gamma and IL-12 are blocking IgE synthesis. IgE production by B cells not only requires the presence of IL-4 or IL-13, but also a physical interaction between T and B cells, involving a number of surface and adhesion molecules such as CD40-CD40L and CD28/CD80. Production of TH2-cytokines is not restricted to T cells as basophils and mast cells can produce them indicating that these cells may be of importance in the synthesis of IgE.

Keywords: JOURNAL ARTICLE REVIEW REVIEW, TUTORIAL Allergens/IMMUNOLOGY Asthma/*IMMUNOLOGY B-Lymphocytes/IMMUNOLOGY Basophils/IMMUNOLOGY Human Hypersensitivity/IMMUNOLOGY IgE/BIOSYNTHESIS/BLOOD/*IMMUNOLOGY Interleukins/BIOSYNTHESIS/IMMUNOLOGY Lymphocyte Transformation T-Lymphocytes/IMMUNOLOGY Th2 Cells/IMMUNOLOGY
990730
A9971189

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1999. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1999. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .